Medicortex Finland Oy

Problem & Solution

Traumatic Brain Injury (TBI), or concussion in its mildest form, are a consequence of an impact to head or a sudden movement of head. Every year, 2.5 M people in Europe, 2.8 M in the USA, and more than 50 M worldwide suffer a TBI. It is typically diagnosed by a neurological examination, based on various responses the suspected patient expresses. Head scans by means CT or MRI have quite poor sensitivity for mild TBI and concussion. Currently, there are no biochemical laboratory tests in routine clinical use, to support the diagnosis of TBI by the physician. The uncertainties in the diagnostics of TBI leave several sufferers of TBI unaware of their condition, which may lead to worse chronic and, even fatal, conditions eventually.
Medicortex' solution for the huge unmet diagnostic need is a rapid test that detects biomarkers of TBI from a sample of urine and saliva. Because of its non-invasive nature, the kit can be used for rapid point-of-care confirming or ruling out TBI.